[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

COVID-19 Impact on Global Tissue Engineered Skin Substitutes, Market Insights and Forecast to 2026

September 2020 | 111 pages | ID: CA6AF1E50DBBEN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Tissue Engineered Skin Substitutes market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Tissue Engineered Skin Substitutes market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Tissue Engineered Skin Substitutes market is segmented into
  • Acellular
  • Cellular Allogeneic
  • Cellular Autologous
  • Others
Segment by Application, the Tissue Engineered Skin Substitutes market is segmented into
  • Burn Injury
  • Diabetic
  • Vascular Ulcer
  • Others
Regional and Country-level Analysis
The Tissue Engineered Skin Substitutes market is analysed and market size information is provided by regions (countries).

The key regions covered in the Tissue Engineered Skin Substitutes market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Tissue Engineered Skin Substitutes Market Share Analysis
Tissue Engineered Skin Substitutes market competitive landscape provides details and data information by players.
The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Tissue Engineered Skin Substitutes business, the date to enter into the Tissue Engineered Skin Substitutes market, Tissue Engineered Skin Substitutes product introduction, recent developments, etc.

The major vendors covered:
  • Amarantus BioScience Holdings
  • Acelity L.P., Inc.
  • BSN medical
  • Integra LifeSciences Corporation
  • Medtronic (Covidien)
  • Molnlycke Health Care
  • Smith & Nephew plc
  • Organogenesis, Inc
1 STUDY COVERAGE

1.1 Tissue Engineered Skin Substitutes Product Introduction
1.2 Market Segments
1.3 Key Tissue Engineered Skin Substitutes Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
  1.4.1 Global Tissue Engineered Skin Substitutes Market Size Growth Rate by Type
  1.4.2 Acellular
  1.4.3 Cellular Allogeneic
  1.4.4 Cellular Autologous
  1.4.5 Others
1.5 Market by Application
  1.5.1 Global Tissue Engineered Skin Substitutes Market Size Growth Rate by Application
  1.5.2 Burn Injury
  1.5.3 Diabetic
  1.5.4 Vascular Ulcer
  1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Tissue Engineered Skin Substitutes Industry Impact
  1.6.1 How the Covid-19 is Affecting the Tissue Engineered Skin Substitutes Industry
    1.6.1.1 Tissue Engineered Skin Substitutes Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Tissue Engineered Skin Substitutes Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Tissue Engineered Skin Substitutes Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 EXECUTIVE SUMMARY

2.1 Global Tissue Engineered Skin Substitutes Market Size Estimates and Forecasts
  2.1.1 Global Tissue Engineered Skin Substitutes Revenue 2015-2026
  2.1.2 Global Tissue Engineered Skin Substitutes Sales 2015-2026
2.2 Tissue Engineered Skin Substitutes Market Size by Region: 2020 Versus 2026
  2.2.1 Global Tissue Engineered Skin Substitutes Retrospective Market Scenario in Sales by Region: 2015-2020
  2.2.2 Global Tissue Engineered Skin Substitutes Retrospective Market Scenario in Revenue by Region: 2015-2020

3 GLOBAL TISSUE ENGINEERED SKIN SUBSTITUTES COMPETITOR LANDSCAPE BY PLAYERS

3.1 Tissue Engineered Skin Substitutes Sales by Manufacturers
  3.1.1 Tissue Engineered Skin Substitutes Sales by Manufacturers (2015-2020)
  3.1.2 Tissue Engineered Skin Substitutes Sales Market Share by Manufacturers (2015-2020)
3.2 Tissue Engineered Skin Substitutes Revenue by Manufacturers
  3.2.1 Tissue Engineered Skin Substitutes Revenue by Manufacturers (2015-2020)
  3.2.2 Tissue Engineered Skin Substitutes Revenue Share by Manufacturers (2015-2020)
  3.2.3 Global Tissue Engineered Skin Substitutes Market Concentration Ratio (CR5 and HHI) (2015-2020)
  3.2.4 Global Top 10 and Top 5 Companies by Tissue Engineered Skin Substitutes Revenue in 2019
  3.2.5 Global Tissue Engineered Skin Substitutes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Tissue Engineered Skin Substitutes Price by Manufacturers
3.4 Tissue Engineered Skin Substitutes Manufacturing Base Distribution, Product Types
  3.4.1 Tissue Engineered Skin Substitutes Manufacturers Manufacturing Base Distribution, Headquarters
  3.4.2 Manufacturers Tissue Engineered Skin Substitutes Product Type
  3.4.3 Date of International Manufacturers Enter into Tissue Engineered Skin Substitutes Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Tissue Engineered Skin Substitutes Market Size by Type (2015-2020)
  4.1.1 Global Tissue Engineered Skin Substitutes Sales by Type (2015-2020)
  4.1.2 Global Tissue Engineered Skin Substitutes Revenue by Type (2015-2020)
  4.1.3 Tissue Engineered Skin Substitutes Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Tissue Engineered Skin Substitutes Market Size Forecast by Type (2021-2026)
  4.2.1 Global Tissue Engineered Skin Substitutes Sales Forecast by Type (2021-2026)
  4.2.2 Global Tissue Engineered Skin Substitutes Revenue Forecast by Type (2021-2026)
  4.2.3 Tissue Engineered Skin Substitutes Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Tissue Engineered Skin Substitutes Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Tissue Engineered Skin Substitutes Market Size by Application (2015-2020)
  5.1.1 Global Tissue Engineered Skin Substitutes Sales by Application (2015-2020)
  5.1.2 Global Tissue Engineered Skin Substitutes Revenue by Application (2015-2020)
  5.1.3 Tissue Engineered Skin Substitutes Price by Application (2015-2020)
5.2 Tissue Engineered Skin Substitutes Market Size Forecast by Application (2021-2026)
  5.2.1 Global Tissue Engineered Skin Substitutes Sales Forecast by Application (2021-2026)
  5.2.2 Global Tissue Engineered Skin Substitutes Revenue Forecast by Application (2021-2026)
  5.2.3 Global Tissue Engineered Skin Substitutes Price Forecast by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Tissue Engineered Skin Substitutes by Country
  6.1.1 North America Tissue Engineered Skin Substitutes Sales by Country
  6.1.2 North America Tissue Engineered Skin Substitutes Revenue by Country
  6.1.3 U.S.
  6.1.4 Canada
6.2 North America Tissue Engineered Skin Substitutes Market Facts & Figures by Type
6.3 North America Tissue Engineered Skin Substitutes Market Facts & Figures by Application

7 EUROPE

7.1 Europe Tissue Engineered Skin Substitutes by Country
  7.1.1 Europe Tissue Engineered Skin Substitutes Sales by Country
  7.1.2 Europe Tissue Engineered Skin Substitutes Revenue by Country
  7.1.3 Germany
  7.1.4 France
  7.1.5 U.K.
  7.1.6 Italy
  7.1.7 Russia
7.2 Europe Tissue Engineered Skin Substitutes Market Facts & Figures by Type
7.3 Europe Tissue Engineered Skin Substitutes Market Facts & Figures by Application

8 ASIA PACIFIC

8.1 Asia Pacific Tissue Engineered Skin Substitutes by Region
  8.1.1 Asia Pacific Tissue Engineered Skin Substitutes Sales by Region
  8.1.2 Asia Pacific Tissue Engineered Skin Substitutes Revenue by Region
  8.1.3 China
  8.1.4 Japan
  8.1.5 South Korea
  8.1.6 India
  8.1.7 Australia
  8.1.8 Taiwan
  8.1.9 Indonesia
  8.1.10 Thailand
  8.1.11 Malaysia
  8.1.12 Philippines
  8.1.13 Vietnam
8.2 Asia Pacific Tissue Engineered Skin Substitutes Market Facts & Figures by Type
8.3 Asia Pacific Tissue Engineered Skin Substitutes Market Facts & Figures by Application

9 LATIN AMERICA

9.1 Latin America Tissue Engineered Skin Substitutes by Country
  9.1.1 Latin America Tissue Engineered Skin Substitutes Sales by Country
  9.1.2 Latin America Tissue Engineered Skin Substitutes Revenue by Country
  9.1.3 Mexico
  9.1.4 Brazil
  9.1.5 Argentina
9.2 Central & South America Tissue Engineered Skin Substitutes Market Facts & Figures by Type
9.3 Central & South America Tissue Engineered Skin Substitutes Market Facts & Figures by Application

10 MIDDLE EAST AND AFRICA

10.1 Middle East and Africa Tissue Engineered Skin Substitutes by Country
  10.1.1 Middle East and Africa Tissue Engineered Skin Substitutes Sales by Country
  10.1.2 Middle East and Africa Tissue Engineered Skin Substitutes Revenue by Country
  10.1.3 Turkey
  10.1.4 Saudi Arabia
  10.1.5 U.A.E
10.2 Middle East and Africa Tissue Engineered Skin Substitutes Market Facts & Figures by Type
10.3 Middle East and Africa Tissue Engineered Skin Substitutes Market Facts & Figures by Application

11 COMPANY PROFILES

11.1 Amarantus BioScience Holdings
  11.1.1 Amarantus BioScience Holdings Corporation Information
  11.1.2 Amarantus BioScience Holdings Description, Business Overview and Total Revenue
  11.1.3 Amarantus BioScience Holdings Sales, Revenue and Gross Margin (2015-2020)
  11.1.4 Amarantus BioScience Holdings Tissue Engineered Skin Substitutes Products Offered
  11.1.5 Amarantus BioScience Holdings Recent Development
11.2 Acelity L.P., Inc.
  11.2.1 Acelity L.P., Inc. Corporation Information
  11.2.2 Acelity L.P., Inc. Description, Business Overview and Total Revenue
  11.2.3 Acelity L.P., Inc. Sales, Revenue and Gross Margin (2015-2020)
  11.2.4 Acelity L.P., Inc. Tissue Engineered Skin Substitutes Products Offered
  11.2.5 Acelity L.P., Inc. Recent Development
11.3 BSN medical
  11.3.1 BSN medical Corporation Information
  11.3.2 BSN medical Description, Business Overview and Total Revenue
  11.3.3 BSN medical Sales, Revenue and Gross Margin (2015-2020)
  11.3.4 BSN medical Tissue Engineered Skin Substitutes Products Offered
  11.3.5 BSN medical Recent Development
11.4 Integra LifeSciences Corporation
  11.4.1 Integra LifeSciences Corporation Corporation Information
  11.4.2 Integra LifeSciences Corporation Description, Business Overview and Total Revenue
  11.4.3 Integra LifeSciences Corporation Sales, Revenue and Gross Margin (2015-2020)
  11.4.4 Integra LifeSciences Corporation Tissue Engineered Skin Substitutes Products Offered
  11.4.5 Integra LifeSciences Corporation Recent Development
11.5 Medtronic (Covidien)
  11.5.1 Medtronic (Covidien) Corporation Information
  11.5.2 Medtronic (Covidien) Description, Business Overview and Total Revenue
  11.5.3 Medtronic (Covidien) Sales, Revenue and Gross Margin (2015-2020)
  11.5.4 Medtronic (Covidien) Tissue Engineered Skin Substitutes Products Offered
  11.5.5 Medtronic (Covidien) Recent Development
11.6 Molnlycke Health Care
  11.6.1 Molnlycke Health Care Corporation Information
  11.6.2 Molnlycke Health Care Description, Business Overview and Total Revenue
  11.6.3 Molnlycke Health Care Sales, Revenue and Gross Margin (2015-2020)
  11.6.4 Molnlycke Health Care Tissue Engineered Skin Substitutes Products Offered
  11.6.5 Molnlycke Health Care Recent Development
11.7 Smith & Nephew plc
  11.7.1 Smith & Nephew plc Corporation Information
  11.7.2 Smith & Nephew plc Description, Business Overview and Total Revenue
  11.7.3 Smith & Nephew plc Sales, Revenue and Gross Margin (2015-2020)
  11.7.4 Smith & Nephew plc Tissue Engineered Skin Substitutes Products Offered
  11.7.5 Smith & Nephew plc Recent Development
11.8 Organogenesis, Inc
  11.8.1 Organogenesis, Inc Corporation Information
  11.8.2 Organogenesis, Inc Description, Business Overview and Total Revenue
  11.8.3 Organogenesis, Inc Sales, Revenue and Gross Margin (2015-2020)
  11.8.4 Organogenesis, Inc Tissue Engineered Skin Substitutes Products Offered
  11.8.5 Organogenesis, Inc Recent Development
11.1 Amarantus BioScience Holdings
  11.1.1 Amarantus BioScience Holdings Corporation Information
  11.1.2 Amarantus BioScience Holdings Description, Business Overview and Total Revenue
  11.1.3 Amarantus BioScience Holdings Sales, Revenue and Gross Margin (2015-2020)
  11.1.4 Amarantus BioScience Holdings Tissue Engineered Skin Substitutes Products Offered
  11.1.5 Amarantus BioScience Holdings Recent Development

12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)

12.1 Tissue Engineered Skin Substitutes Market Estimates and Projections by Region
  12.1.1 Global Tissue Engineered Skin Substitutes Sales Forecast by Regions 2021-2026
  12.1.2 Global Tissue Engineered Skin Substitutes Revenue Forecast by Regions 2021-2026
12.2 North America Tissue Engineered Skin Substitutes Market Size Forecast (2021-2026)
  12.2.1 North America: Tissue Engineered Skin Substitutes Sales Forecast (2021-2026)
  12.2.2 North America: Tissue Engineered Skin Substitutes Revenue Forecast (2021-2026)
  12.2.3 North America: Tissue Engineered Skin Substitutes Market Size Forecast by Country (2021-2026)
12.3 Europe Tissue Engineered Skin Substitutes Market Size Forecast (2021-2026)
  12.3.1 Europe: Tissue Engineered Skin Substitutes Sales Forecast (2021-2026)
  12.3.2 Europe: Tissue Engineered Skin Substitutes Revenue Forecast (2021-2026)
  12.3.3 Europe: Tissue Engineered Skin Substitutes Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Tissue Engineered Skin Substitutes Market Size Forecast (2021-2026)
  12.4.1 Asia Pacific: Tissue Engineered Skin Substitutes Sales Forecast (2021-2026)
  12.4.2 Asia Pacific: Tissue Engineered Skin Substitutes Revenue Forecast (2021-2026)
  12.4.3 Asia Pacific: Tissue Engineered Skin Substitutes Market Size Forecast by Region (2021-2026)
12.5 Latin America Tissue Engineered Skin Substitutes Market Size Forecast (2021-2026)
  12.5.1 Latin America: Tissue Engineered Skin Substitutes Sales Forecast (2021-2026)
  12.5.2 Latin America: Tissue Engineered Skin Substitutes Revenue Forecast (2021-2026)
  12.5.3 Latin America: Tissue Engineered Skin Substitutes Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Tissue Engineered Skin Substitutes Market Size Forecast (2021-2026)
  12.6.1 Middle East and Africa: Tissue Engineered Skin Substitutes Sales Forecast (2021-2026)
  12.6.2 Middle East and Africa: Tissue Engineered Skin Substitutes Revenue Forecast (2021-2026)
  12.6.3 Middle East and Africa: Tissue Engineered Skin Substitutes Market Size Forecast by Country (2021-2026)

13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS

13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Tissue Engineered Skin Substitutes Players (Opinion Leaders)

14 VALUE CHAIN AND SALES CHANNELS ANALYSIS

14.1 Value Chain Analysis
14.2 Tissue Engineered Skin Substitutes Customers
14.3 Sales Channels Analysis
  14.3.1 Sales Channels
  14.3.2 Distributors

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Research Methodology
  16.1.1 Methodology/Research Approach
  16.1.2 Data Source
16.2 Author Details
LIST OF TABLES

Table 1. Tissue Engineered Skin Substitutes Market Segments
Table 2. Ranking of Global Top Tissue Engineered Skin Substitutes Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Tissue Engineered Skin Substitutes Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Acellular
Table 5. Major Manufacturers of Cellular Allogeneic
Table 6. Major Manufacturers of Cellular Autologous
Table 7. Major Manufacturers of Others
Table 8. COVID-19 Impact Global Market: (Four Tissue Engineered Skin Substitutes Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Tissue Engineered Skin Substitutes Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Tissue Engineered Skin Substitutes Players to Combat Covid-19 Impact
Table 13. Global Tissue Engineered Skin Substitutes Market Size Growth Rate by Application 2020-2026 (K Units)
Table 14. Global Tissue Engineered Skin Substitutes Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 15. Global Tissue Engineered Skin Substitutes Sales by Regions 2015-2020 (K Units)
Table 16. Global Tissue Engineered Skin Substitutes Sales Market Share by Regions (2015-2020)
Table 17. Global Tissue Engineered Skin Substitutes Revenue by Regions 2015-2020 (US$ Million)
Table 18. Global Tissue Engineered Skin Substitutes Sales by Manufacturers (2015-2020) (K Units)
Table 19. Global Tissue Engineered Skin Substitutes Sales Share by Manufacturers (2015-2020)
Table 20. Global Tissue Engineered Skin Substitutes Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Tissue Engineered Skin Substitutes by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tissue Engineered Skin Substitutes as of 2019)
Table 22. Tissue Engineered Skin Substitutes Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Tissue Engineered Skin Substitutes Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Tissue Engineered Skin Substitutes Price (2015-2020) (USD/Unit)
Table 25. Tissue Engineered Skin Substitutes Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Tissue Engineered Skin Substitutes Product Type
Table 27. Date of International Manufacturers Enter into Tissue Engineered Skin Substitutes Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Tissue Engineered Skin Substitutes Sales by Type (2015-2020) (K Units)
Table 30. Global Tissue Engineered Skin Substitutes Sales Share by Type (2015-2020)
Table 31. Global Tissue Engineered Skin Substitutes Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Tissue Engineered Skin Substitutes Revenue Share by Type (2015-2020)
Table 33. Tissue Engineered Skin Substitutes Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 34. Global Tissue Engineered Skin Substitutes Sales by Application (2015-2020) (K Units)
Table 35. Global Tissue Engineered Skin Substitutes Sales Share by Application (2015-2020)
Table 36. North America Tissue Engineered Skin Substitutes Sales by Country (2015-2020) (K Units)
Table 37. North America Tissue Engineered Skin Substitutes Sales Market Share by Country (2015-2020)
Table 38. North America Tissue Engineered Skin Substitutes Revenue by Country (2015-2020) (US$ Million)
Table 39. North America Tissue Engineered Skin Substitutes Revenue Market Share by Country (2015-2020)
Table 40. North America Tissue Engineered Skin Substitutes Sales by Type (2015-2020) (K Units)
Table 41. North America Tissue Engineered Skin Substitutes Sales Market Share by Type (2015-2020)
Table 42. North America Tissue Engineered Skin Substitutes Sales by Application (2015-2020) (K Units)
Table 43. North America Tissue Engineered Skin Substitutes Sales Market Share by Application (2015-2020)
Table 44. Europe Tissue Engineered Skin Substitutes Sales by Country (2015-2020) (K Units)
Table 45. Europe Tissue Engineered Skin Substitutes Sales Market Share by Country (2015-2020)
Table 46. Europe Tissue Engineered Skin Substitutes Revenue by Country (2015-2020) (US$ Million)
Table 47. Europe Tissue Engineered Skin Substitutes Revenue Market Share by Country (2015-2020)
Table 48. Europe Tissue Engineered Skin Substitutes Sales by Type (2015-2020) (K Units)
Table 49. Europe Tissue Engineered Skin Substitutes Sales Market Share by Type (2015-2020)
Table 50. Europe Tissue Engineered Skin Substitutes Sales by Application (2015-2020) (K Units)
Table 51. Europe Tissue Engineered Skin Substitutes Sales Market Share by Application (2015-2020)
Table 52. Asia Pacific Tissue Engineered Skin Substitutes Sales by Region (2015-2020) (K Units)
Table 53. Asia Pacific Tissue Engineered Skin Substitutes Sales Market Share by Region (2015-2020)
Table 54. Asia Pacific Tissue Engineered Skin Substitutes Revenue by Region (2015-2020) (US$ Million)
Table 55. Asia Pacific Tissue Engineered Skin Substitutes Revenue Market Share by Region (2015-2020)
Table 56. Asia Pacific Tissue Engineered Skin Substitutes Sales by Type (2015-2020) (K Units)
Table 57. Asia Pacific Tissue Engineered Skin Substitutes Sales Market Share by Type (2015-2020)
Table 58. Asia Pacific Tissue Engineered Skin Substitutes Sales by Application (2015-2020) (K Units)
Table 59. Asia Pacific Tissue Engineered Skin Substitutes Sales Market Share by Application (2015-2020)
Table 60. Latin America Tissue Engineered Skin Substitutes Sales by Country (2015-2020) (K Units)
Table 61. Latin America Tissue Engineered Skin Substitutes Sales Market Share by Country (2015-2020)
Table 62. Latin Americaa Tissue Engineered Skin Substitutes Revenue by Country (2015-2020) (US$ Million)
Table 63. Latin America Tissue Engineered Skin Substitutes Revenue Market Share by Country (2015-2020)
Table 64. Latin America Tissue Engineered Skin Substitutes Sales by Type (2015-2020) (K Units)
Table 65. Latin America Tissue Engineered Skin Substitutes Sales Market Share by Type (2015-2020)
Table 66. Latin America Tissue Engineered Skin Substitutes Sales by Application (2015-2020) (K Units)
Table 67. Latin America Tissue Engineered Skin Substitutes Sales Market Share by Application (2015-2020)
Table 68. Middle East and Africa Tissue Engineered Skin Substitutes Sales by Country (2015-2020) (K Units)
Table 69. Middle East and Africa Tissue Engineered Skin Substitutes Sales Market Share by Country (2015-2020)
Table 70. Middle East and Africa Tissue Engineered Skin Substitutes Revenue by Country (2015-2020) (US$ Million)
Table 71. Middle East and Africa Tissue Engineered Skin Substitutes Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Tissue Engineered Skin Substitutes Sales by Type (2015-2020) (K Units)
Table 73. Middle East and Africa Tissue Engineered Skin Substitutes Sales Market Share by Type (2015-2020)
Table 74. Middle East and Africa Tissue Engineered Skin Substitutes Sales by Application (2015-2020) (K Units)
Table 75. Middle East and Africa Tissue Engineered Skin Substitutes Sales Market Share by Application (2015-2020)
Table 76. Amarantus BioScience Holdings Corporation Information
Table 77. Amarantus BioScience Holdings Description and Major Businesses
Table 78. Amarantus BioScience Holdings Tissue Engineered Skin Substitutes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 79. Amarantus BioScience Holdings Product
Table 80. Amarantus BioScience Holdings Recent Development
Table 81. Acelity L.P., Inc. Corporation Information
Table 82. Acelity L.P., Inc. Description and Major Businesses
Table 83. Acelity L.P., Inc. Tissue Engineered Skin Substitutes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 84. Acelity L.P., Inc. Product
Table 85. Acelity L.P., Inc. Recent Development
Table 86. BSN medical Corporation Information
Table 87. BSN medical Description and Major Businesses
Table 88. BSN medical Tissue Engineered Skin Substitutes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 89. BSN medical Product
Table 90. BSN medical Recent Development
Table 91. Integra LifeSciences Corporation Corporation Information
Table 92. Integra LifeSciences Corporation Description and Major Businesses
Table 93. Integra LifeSciences Corporation Tissue Engineered Skin Substitutes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 94. Integra LifeSciences Corporation Product
Table 95. Integra LifeSciences Corporation Recent Development
Table 96. Medtronic (Covidien) Corporation Information
Table 97. Medtronic (Covidien) Description and Major Businesses
Table 98. Medtronic (Covidien) Tissue Engineered Skin Substitutes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 99. Medtronic (Covidien) Product
Table 100. Medtronic (Covidien) Recent Development
Table 101. Molnlycke Health Care Corporation Information
Table 102. Molnlycke Health Care Description and Major Businesses
Table 103. Molnlycke Health Care Tissue Engineered Skin Substitutes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 104. Molnlycke Health Care Product
Table 105. Molnlycke Health Care Recent Development
Table 106. Smith & Nephew plc Corporation Information
Table 107. Smith & Nephew plc Description and Major Businesses
Table 108. Smith & Nephew plc Tissue Engineered Skin Substitutes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 109. Smith & Nephew plc Product
Table 110. Smith & Nephew plc Recent Development
Table 111. Organogenesis, Inc Corporation Information
Table 112. Organogenesis, Inc Description and Major Businesses
Table 113. Organogenesis, Inc Tissue Engineered Skin Substitutes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 114. Organogenesis, Inc Product
Table 115. Organogenesis, Inc Recent Development
Table 116. Global Tissue Engineered Skin Substitutes Sales Forecast by Regions (2021-2026) (K Units)
Table 117. Global Tissue Engineered Skin Substitutes Sales Market Share Forecast by Regions (2021-2026)
Table 118. Global Tissue Engineered Skin Substitutes Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 119. Global Tissue Engineered Skin Substitutes Revenue Market Share Forecast by Regions (2021-2026)
Table 120. North America: Tissue Engineered Skin Substitutes Sales Forecast by Country (2021-2026) (K Units)
Table 121. North America: Tissue Engineered Skin Substitutes Revenue Forecast by Country (2021-2026) (US$ Million)
Table 122. Europe: Tissue Engineered Skin Substitutes Sales Forecast by Country (2021-2026) (K Units)
Table 123. Europe: Tissue Engineered Skin Substitutes Revenue Forecast by Country (2021-2026) (US$ Million)
Table 124. Asia Pacific: Tissue Engineered Skin Substitutes Sales Forecast by Region (2021-2026) (K Units)
Table 125. Asia Pacific: Tissue Engineered Skin Substitutes Revenue Forecast by Region (2021-2026) (US$ Million)
Table 126. Latin America: Tissue Engineered Skin Substitutes Sales Forecast by Country (2021-2026) (K Units)
Table 127. Latin America: Tissue Engineered Skin Substitutes Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Middle East and Africa: Tissue Engineered Skin Substitutes Sales Forecast by Country (2021-2026) (K Units)
Table 129. Middle East and Africa: Tissue Engineered Skin Substitutes Revenue Forecast by Country (2021-2026) (US$ Million)
Table 130. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 131. Key Challenges
Table 132. Market Risks
Table 133. Main Points Interviewed from Key Tissue Engineered Skin Substitutes Players
Table 134. Tissue Engineered Skin Substitutes Customers List
Table 135. Tissue Engineered Skin Substitutes Distributors List
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Tissue Engineered Skin Substitutes Product Picture
Figure 2. Global Tissue Engineered Skin Substitutes Sales Market Share by Type in 2020 & 2026
Figure 3. Acellular Product Picture
Figure 4. Cellular Allogeneic Product Picture
Figure 5. Cellular Autologous Product Picture
Figure 6. Others Product Picture
Figure 7. Global Tissue Engineered Skin Substitutes Sales Market Share by Application in 2020 & 2026
Figure 8. Burn Injury
Figure 9. Diabetic
Figure 10. Vascular Ulcer
Figure 11. Others
Figure 12. Tissue Engineered Skin Substitutes Report Years Considered
Figure 13. Global Tissue Engineered Skin Substitutes Market Size 2015-2026 (US$ Million)
Figure 14. Global Tissue Engineered Skin Substitutes Sales 2015-2026 (K Units)
Figure 15. Global Tissue Engineered Skin Substitutes Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Tissue Engineered Skin Substitutes Sales Market Share by Region (2015-2020)
Figure 17. Global Tissue Engineered Skin Substitutes Sales Market Share by Region in 2019
Figure 18. Global Tissue Engineered Skin Substitutes Revenue Market Share by Region (2015-2020)
Figure 19. Global Tissue Engineered Skin Substitutes Revenue Market Share by Region in 2019
Figure 20. Global Tissue Engineered Skin Substitutes Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Tissue Engineered Skin Substitutes Revenue in 2019
Figure 22. Tissue Engineered Skin Substitutes Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Tissue Engineered Skin Substitutes Sales Market Share by Type (2015-2020)
Figure 24. Global Tissue Engineered Skin Substitutes Sales Market Share by Type in 2019
Figure 25. Global Tissue Engineered Skin Substitutes Revenue Market Share by Type (2015-2020)
Figure 26. Global Tissue Engineered Skin Substitutes Revenue Market Share by Type in 2019
Figure 27. Global Tissue Engineered Skin Substitutes Market Share by Price Range (2015-2020)
Figure 28. Global Tissue Engineered Skin Substitutes Sales Market Share by Application (2015-2020)
Figure 29. Global Tissue Engineered Skin Substitutes Sales Market Share by Application in 2019
Figure 30. Global Tissue Engineered Skin Substitutes Revenue Market Share by Application (2015-2020)
Figure 31. Global Tissue Engineered Skin Substitutes Revenue Market Share by Application in 2019
Figure 32. North America Tissue Engineered Skin Substitutes Sales Growth Rate 2015-2020 (K Units)
Figure 33. North America Tissue Engineered Skin Substitutes Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Tissue Engineered Skin Substitutes Sales Market Share by Country in 2019
Figure 35. North America Tissue Engineered Skin Substitutes Revenue Market Share by Country in 2019
Figure 36. U.S. Tissue Engineered Skin Substitutes Sales Growth Rate (2015-2020) (K Units)
Figure 37. U.S. Tissue Engineered Skin Substitutes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Tissue Engineered Skin Substitutes Sales Growth Rate (2015-2020) (K Units)
Figure 39. Canada Tissue Engineered Skin Substitutes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Tissue Engineered Skin Substitutes Market Share by Type in 2019
Figure 41. North America Tissue Engineered Skin Substitutes Market Share by Application in 2019
Figure 42. Europe Tissue Engineered Skin Substitutes Sales Growth Rate 2015-2020 (K Units)
Figure 43. Europe Tissue Engineered Skin Substitutes Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Tissue Engineered Skin Substitutes Sales Market Share by Country in 2019
Figure 45. Europe Tissue Engineered Skin Substitutes Revenue Market Share by Country in 2019
Figure 46. Germany Tissue Engineered Skin Substitutes Sales Growth Rate (2015-2020) (K Units)
Figure 47. Germany Tissue Engineered Skin Substitutes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Tissue Engineered Skin Substitutes Sales Growth Rate (2015-2020) (K Units)
Figure 49. France Tissue Engineered Skin Substitutes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Tissue Engineered Skin Substitutes Sales Growth Rate (2015-2020) (K Units)
Figure 51. U.K. Tissue Engineered Skin Substitutes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Tissue Engineered Skin Substitutes Sales Growth Rate (2015-2020) (K Units)
Figure 53. Italy Tissue Engineered Skin Substitutes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Tissue Engineered Skin Substitutes Sales Growth Rate (2015-2020) (K Units)
Figure 55. Russia Tissue Engineered Skin Substitutes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Tissue Engineered Skin Substitutes Market Share by Type in 2019
Figure 57. Europe Tissue Engineered Skin Substitutes Market Share by Application in 2019
Figure 58. Asia Pacific Tissue Engineered Skin Substitutes Sales Growth Rate 2015-2020 (K Units)
Figure 59. Asia Pacific Tissue Engineered Skin Substitutes Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Tissue Engineered Skin Substitutes Sales Market Share by Region in 2019
Figure 61. Asia Pacific Tissue Engineered Skin Substitutes Revenue Market Share by Region in 2019
Figure 62. China Tissue Engineered Skin Substitutes Sales Growth Rate (2015-2020) (K Units)
Figure 63. China Tissue Engineered Skin Substitutes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Tissue Engineered Skin Substitutes Sales Growth Rate (2015-2020) (K Units)
Figure 65. Japan Tissue Engineered Skin Substitutes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Tissue Engineered Skin Substitutes Sales Growth Rate (2015-2020) (K Units)
Figure 67. South Korea Tissue Engineered Skin Substitutes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Tissue Engineered Skin Substitutes Sales Growth Rate (2015-2020) (K Units)
Figure 69. India Tissue Engineered Skin Substitutes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Tissue Engineered Skin Substitutes Sales Growth Rate (2015-2020) (K Units)
Figure 71. Australia Tissue Engineered Skin Substitutes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Tissue Engineered Skin Substitutes Sales Growth Rate (2015-2020) (K Units)
Figure 73. Taiwan Tissue Engineered Skin Substitutes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Tissue Engineered Skin Substitutes Sales Growth Rate (2015-2020) (K Units)
Figure 75. Indonesia Tissue Engineered Skin Substitutes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Tissue Engineered Skin Substitutes Sales Growth Rate (2015-2020) (K Units)
Figure 77. Thailand Tissue Engineered Skin Substitutes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Tissue Engineered Skin Substitutes Sales Growth Rate (2015-2020) (K Units)
Figure 79. Malaysia Tissue Engineered Skin Substitutes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Tissue Engineered Skin Substitutes Sales Growth Rate (2015-2020) (K Units)
Figure 81. Philippines Tissue Engineered Skin Substitutes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Tissue Engineered Skin Substitutes Sales Growth Rate (2015-2020) (K Units)
Figure 83. Vietnam Tissue Engineered Skin Substitutes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Tissue Engineered Skin Substitutes Market Share by Type in 2019
Figure 85. Asia Pacific Tissue Engineered Skin Substitutes Market Share by Application in 2019
Figure 86. Latin America Tissue Engineered Skin Substitutes Sales Growth Rate 2015-2020 (K Units)
Figure 87. Latin America Tissue Engineered Skin Substitutes Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Tissue Engineered Skin Substitutes Sales Market Share by Country in 2019
Figure 89. Latin America Tissue Engineered Skin Substitutes Revenue Market Share by Country in 2019
Figure 90. Mexico Tissue Engineered Skin Substitutes Sales Growth Rate (2015-2020) (K Units)
Figure 91. Mexico Tissue Engineered Skin Substitutes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Tissue Engineered Skin Substitutes Sales Growth Rate (2015-2020) (K Units)
Figure 93. Brazil Tissue Engineered Skin Substitutes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Tissue Engineered Skin Substitutes Sales Growth Rate (2015-2020) (K Units)
Figure 95. Argentina Tissue Engineered Skin Substitutes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Tissue Engineered Skin Substitutes Market Share by Type in 2019
Figure 97. Latin America Tissue Engineered Skin Substitutes Market Share by Application in 2019
Figure 98. Middle East and Africa Tissue Engineered Skin Substitutes Sales Growth Rate 2015-2020 (K Units)
Figure 99. Middle East and Africa Tissue Engineered Skin Substitutes Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Tissue Engineered Skin Substitutes Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Tissue Engineered Skin Substitutes Revenue Market Share by Country in 2019
Figure 102. Turkey Tissue Engineered Skin Substitutes Sales Growth Rate (2015-2020) (K Units)
Figure 103. Turkey Tissue Engineered Skin Substitutes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Tissue Engineered Skin Substitutes Sales Growth Rate (2015-2020) (K Units)
Figure 105. Saudi Arabia Tissue Engineered Skin Substitutes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Tissue Engineered Skin Substitutes Sales Growth Rate (2015-2020) (K Units)
Figure 107. U.A.E Tissue Engineered Skin Substitutes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Tissue Engineered Skin Substitutes Market Share by Type in 2019
Figure 109. Middle East and Africa Tissue Engineered Skin Substitutes Market Share by Application in 2019
Figure 110. Amarantus BioScience Holdings Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Acelity L.P., Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. BSN medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Integra LifeSciences Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Medtronic (Covidien) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Molnlycke Health Care Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Smith & Nephew plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Organogenesis, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. North America Tissue Engineered Skin Substitutes Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. North America Tissue Engineered Skin Substitutes Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Europe Tissue Engineered Skin Substitutes Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 121. Europe Tissue Engineered Skin Substitutes Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Asia Pacific Tissue Engineered Skin Substitutes Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 123. Asia Pacific Tissue Engineered Skin Substitutes Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Latin America Tissue Engineered Skin Substitutes Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 125. Latin America Tissue Engineered Skin Substitutes Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Middle East and Africa Tissue Engineered Skin Substitutes Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 127. Middle East and Africa Tissue Engineered Skin Substitutes Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 128. Porter's Five Forces Analysis
Figure 129. Channels of Distribution
Figure 130. Distributors Profiles
Figure 131. Bottom-up and Top-down Approaches for This Report
Figure 132. Data Triangulation
Figure 133. Key Executives Interviewed


More Publications